Pharmaceuticals News

The pharmaceuticals news email from Wiser has been specifically designed for anyone with an interest in the industry. This includes medical practitioners, investors and those involved in research and development. By its very nature, the pharmaceutical industry is subject to constant change. It is a research-driven industry with companies spending much of their revenues developing new medicines and vaccines. As a result patients are able to get new and more effective treatments. This is helping to increase the life expectancy of individuals in most countries. But there are challenges. The costs of the research and development can be large which puts up the price of drugs, while governments and the medical industry argue to try to keep prices as low as possible. The industry also faces challenges from alternatives, both legal (through generic drugs) and illegal (through black market economies). To follow the latest developments in this industry you should sign up for the pharmaceuticals news email from Wiser. It is the best way to find must-read articles on the topic from around the web.

Recent Pharmaceuticals News Coverage
 
Your Weekly Recommendations Friday, November 24, 2017
 
Recommended for you
Teva Pharmaceutical Is Reportedly Planning Thousands of Layoffs in the U.S.
Fortune Magazine • Reuters
Teva Pharmaceutical set for major layoffs in Israel, U.S.: report
Reuters • Reuters Staff
Teva Pharmaceutical set for major layoffs in Israel, U.S. -report
Reuters • Reuters Staff
ChemoCentryx Looks Like An Attractive Investment
Seeking Alpha • Biopharmaceutical Wolf
Coffee: No Harm, No Foul If Only 4 Cups Daily
MedPage Today • Alexandria Bachert Mph
Restasis Buyers Hit Allergan With An Anti-Trust Lawsuit
Seeking Alpha • Shock Exchange
Perspectives: Orphan Drug Tax Credit Gives People With Rare Diseases Hope. GOP Plan Could Crush That
Kaiser Health News
Alex Azar Is Just Latest In List Of People Tied To Industry Filling Trump’s Top Health Spots
Kaiser Health News
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
New England Journal of Medicine • Anna M. Diehl
U.S. FDA approves first two-drug HIV regimen in win for GSK
Reuters • Reuters Staff
 
Recommended for You
Pharmaceuticals
Teva Pharmaceutical Is Reportedly Planning Thousands of Layoffs in the U.S.
Fortune MagazineReuters
Teva Pharmaceutical Industries (teva, +1.09%) is expected to cut 20-25% of its workforce in Israel, where it employs 6,860 people, and a few thousand more jobs are to go in the United States, financial news website Calcalist said on Thursday. The world’s...
Share
Health Care Industry, Pharmaceuticals
Teva Pharmaceutical set for major layoffs in Israel, U.S.: report
ReutersReuters Staff
TEL AVIV () - Teva Pharmaceutical Industries is expected to cut 20-25 percent of its 6,860 workers in Israel and a few thousand more in the United States, financial news website Calcalist reported on Thursday. The world’s largest generic drugmaker will send...
Share
Pharmaceuticals
Teva Pharmaceutical set for major layoffs in Israel, U.S. -report
ReutersReuters Staff
TEL AVIV () - Teva Pharmaceutical Industries is expected to cut 20-25 percent of its 6,860 workers in Israel and a few thousand more in the United States, financial news website Calcalist reported on Thursday. The world’s largest generic drugmaker will send...
Share
Health Finance, Pharmaceuticals
ChemoCentryx Looks Like An Attractive Investment
Seeking AlphaBiopharmaceutical Wolf
Summary ChemoCentryx has an interesting pipeline and a strong cash position. Their kidney disease franchise keeps progressing and obtained encouraging results in clinical studies. This report will take a look at their drug candidates and their ongoing phase 3 trial ADVOCATE. The...
Share
Epidemiology, Evidence-Based Medicine
Coffee: No Harm, No Foul If Only 4 Cups Daily
MedPage TodayAlexandria Bachert Mph
Daily consumption of coffee is safe within usual patterns of intake and more likely to benefit health than to harm it, British researchers concluded. Analysis of more than 200 studies found that drinking three to four cups of coffee a day (400...
Share
Health Finance, Patent Troll
Restasis Buyers Hit Allergan With An Anti-Trust Lawsuit
Seeking AlphaShock Exchange
Summary Restasis buyers hit AGN with an anti-trust lawsuit. The suit claims its blocked low-cost generics from entering the market at customers' expense. I believe the lawsuit has credibility. A sizable legal payout could hurt liquidity and sentiment of AGN. AGN remains...
Share
Cancer, Health Reform
Perspectives: Orphan Drug Tax Credit Gives People With Rare Diseases Hope. GOP Plan Could Crush That
Kaiser Health News
Read recent commentaries about drug-cost issues.
Share
Cancer, GlaxoSmithKline plc
Alex Azar Is Just Latest In List Of People Tied To Industry Filling Trump’s Top Health Spots
Kaiser Health News
News outlets report on stories related to pharmaceutical pricing.
Share
Health Care Industry, Health & Medicine
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
New England Journal of MedicineAnna M. Diehl
Nonalcoholic steatohepatitis is a major cause of cirrhosis and liver cancer. It is associated with visceral adiposity and the metabolic syndrome and is nearly as common as type 2 diabetes. Metabolic stress, inflammation, and fibrosis are the primary pathogenic mechanisms. Disclosure forms...
Share
Asthma, GlaxoSmithKline plc
U.S. FDA approves first two-drug HIV regimen in win for GSK
ReutersReuters Staff
() - The U.S. Food and Drug Administration has approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines. The green light is...
Share